Wenn das folgende stimmt, wird klar, warum die Börse nichtmal über die PR hustet und die US-Boards die Sache kaum beachten.
Aber lest selbst:
The OTCjournal.com Newsletter is owned by MarketByte, LLC.
According to the OTC Journal disclaimer, MarketByte LLC has been compensated a fee of 250,000 free trading shares of Calypte common stock by First Stage Capital for coverage of Calypte Biomed. On August 12, 2002, MarketByte LLC entered into an agreement directly with Calypte Biomed to continue coverage of the company through October 31, 2002. Calypte Biomed compensated $25,000 cash as compensation, and an additional 300,000 shares of free trading stock were compensated by a third party on behalf of the company. On November 1, 2002, MarketByte LLC and Calypte Biomed to agreed to renew the agreement to extend through January 31, 2003 in return for $25,000 in cash, and an additional 300,000 shares of free trading stock were compensated by a third party.
Smoky
|
Thread abonnieren
